StockVaultt

Natco Pharma LTD analysis on 30 Mar 24

Long
NSE:NATCOPHARM   NATCO PHARMA LTD
Natco Pharma LTD analysis on 30 Mar 24
Fundamentally Analysis
Good fundamental stock
promoter holding 49%
FII holding 13.72%
less debt than the reserve
debt 247 cr
Reserve 5257 cr
stock PE is less than industry PE
Overall all time PE 20.9
Stock PE 14.1
Industry PE 32

Technical Analysis
Formation of Head & Shoulder
breakout after Aug 2021 @ 900
breakout and support done @ 900
keep stop loss 740
target 950 - 1000 - 1050 - 1150 - 1200
head and shoulder target 1330
If sustained above 1300 target 1400 - 1450 - 1500 - 1550
Comment:
2ND TARGET HIT 1037 (HIGH NEAR TO 3RD TARGET 1050)

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.